Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) per share from the same period last year.
Organogenesis Holdings Q3 EPS $0.09 Beats $0.06 Estimate, Sales $113.80M Beat $112.67M Estimate
Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.06 by 50 percent. This is a 52.63 percent decrease over earnings of $0.19 per share from
